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Case Report
Langerhans cell histiocytosis ofthe perianal region
A Foster, M Epanoimeritakis, J Moorehead
Accepted 5 February 2003
A 19 year-old male presented to the surgical
outpatients with a two year history of a perianal
lesion which had recently increased in size. He
reported thatit was only occasionally painful but
his main problem was that of surface bleeding.
He gave no history of trauma. However, he did
report that he had had a neurosurgical procedure
many years previously.
Examination showed two flat sessile lesions on
each buttock in the perianal region which were
granulomatousinappearance.Therewasevidence
ofsurface bleeding. (figure) These findings were
highly suspicious ofsquamous cell carcinoma of
the anus. He was boarded for biopsy, which was
performed without complication.
The histopathology showed ulceration of the
epidermis and underlying sheets of histiocytic
cells, appearances in keeping with Langerhan's
cell histiocytosis or Histiocytosis X. There was
no evidence of malignancy.
The lesions were subsequently excised and the
woundwasallowedtohealbysecondaryintention
and did not require grafting.
Figure
When he was informed of the diagnosis, he
reportedthathispreviousneurosurgicalprocedure
had been performed for this condition.
Examination of the archived charts confirmed
this. Indeed, 11 years priorto this incidenthehad
attended a neurosurgical unit with a two-year
historyofproptosisaffectingtherighteye.Routine
neurologicalexaminationwasnormalexceptthat
his right eye was displaced downwards and
forwards. A CT scan showed destruction of the
bone in the right anterior frontal region with a
softtissuemassextendingintotheanteriorcranial
fossa, in keeping with an extra-dural mass. A
rightfrontal craniotomy had been performed and
the lesion was removed in apiecemeal fashion. It
was felt at the time of the procedure that not all
the lesion had been excised; however, the bony
defect was repaired with titanium gauze. Two
months later he underwent a course of
chemotherapy, consisting of prednisolone,
vincristinefollowedbymercaptopurine. Oneyear
later he developed diabetes insipidus. However
a repeat CT scan had shown no pituitary
involvement. He responded well to nasal
desmopressin. A repeat CT scan six months later
showed no evidence of further disease and he
subsequently underwent a titanium cranioplasty
to cover the bony defect. He was kept under
review with no evidence ofrecurrence and aMRI
fouryearslatershowednoevidenceofrecurrence
of disease.
He remained well with no symptoms until his
attendance at the surgical outpatients five years
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later. Since then an isotope bone scan and CT
abdomenandpelvishavebeennormal. Heremains
under review.
DISCUSSION
Langerhan'scellhistiocytosis (previouslyknown
ashistiocytosisX)isarareconditionthatgenerally
affectschildren. Itcomprisesagroupofdisorders
thatdemonstrateproliferationoftheLangerhan's
cell derived from bone marrow.
Theclinicalspectrumiswidebutcanbegenerally
classified according to three distinct clinical
entities;
1. Sib-Letterer-Siwe disease. An acute
progressive disseminated disease, which
presents with fever, anaemia, organomegaly
and thrombocytopenia. Death may occur due
to infections or progressive anaemia.
2. Hand-Schuller-Christian disease. An
intermediate clinical form aka multifocal
eosinophilic granuloma. This often presents
with the classical triad of diabetes, proptosis
andbonylesions. Thissyndromewouldindeed
be attributable to the case in question.
3. Hasimoto-Pritzkerdisease. Acongenitalform
ofthe disease that is often self-limiting.
The underlying cause is still as yet unknown.
Various hypotheses have been cited as to the
cause ranging from reactive processes to
neoplastic processes.
The annual incidence is in the range of 5per
million peryear with a male: female ratio of2:1.
Theclassicalmultifocalform,whichhasoccurred
in this patient only rarely, presents with all three
of the triad of proptosis, diabetes insipidus and
bony defects.
When a patient is diagnosed with Langerhan's
Cell Histiocytosis, a standardised evaluation is
usually undertaken; this has been developed by
theHistiocyteSociety.Routinebloodtestsshould
include full blood count, liver function tests and
coagulation studies. Due to the possibility of
diabetesinsipidusaurineosmolalityismandatory,
as is a chest radiograph.
Morespecific tests arerequireddepending on the
site of the suspected lesion.
Treatment ofthe condition is dependentupon the
extentofthediseaseandupontheinvolvedorgans.
Cessationofsmokingisessential. Glucocorticoids
havebeenusedeithertopically forskinlesions or
systemically for more invasive disease.
Chemotherapeutic agents are indicated for
multisystem disease. Trials have shown
combinations of vinblastine, etoposide and
prednisolone for a period of six weeks to be
effective, followed by mercaptopurine,
vinblastine and prednisolone for one year.
Prognosis is variable upon the type of disease
encountered. Unifocal LCH generally has an
excellent prognosis whereas multifocal disease
has a much poorer prognosis. Letterer-Siwe
diseasehasanevenpoorerprognosisandmortality
can reach 50%.
Relapse is not uncommon and can occurup to 10
years after the disappearance of the original
disease.
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